CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS (UNAUDITED) - USD ($)	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
Cash Flows from Operating Activities
Net Loss	$ (24,620,395)	$ (1,035,720)
Adjustments to reconcile net (loss) to net cash used in operating activities:
Non-cash stock compensation expense	1,158,058	151,741
Non-cash stock option expense	519,094	206,545
Depreciation expense	59,075	5,020
Shares issued for operating expenses	2,003,210
Non-cash lease expense	23,695,139	1,191,431
Gain on sale of Treasury Bills	(31,014)
Issuance of shares for revenue share agreement	1,704,549
Termination of revenue share agreement	28,174,148
Modification of warrants	259,075
Non-cash financing changes associated with short term business financing	325,290
Loss on debt extinguishment	58,579
Loan forgiveness – SBA – PPP loan		(516,225)
Warrant expense		3,480,725
(Increase) Decrease in:
Processor retained funds	804,991	(7,309,323)
Receivables from OTAs	(12,868,602)
Prepaid expense and other assets	(3,791,886)	(1,265,751)
Security deposits	(9,402,784)	(4,416,722)
(Decrease) Increase in:
Accounts payable and accrued expenses	1,425,308	(555,427)
Operating lease liabilities	(17,485,034)	(2,942,616)
Rents received in advance	982,946	(539,951)
Accrued Income Taxes	15,702
Net cash used in operating activities	(7,014,551)	(13,546,273)
Cash Flows from Investing Activities
Purchase of furniture and equipment and leaseholds	(921,414)	(44,300)
Proceeds from the sale of (purchase of) Treasury Bills	2,692,396	(50,658)
Net cash provided by (used in) investing activities	1,770,982	(94,958)
Cash Flows from Financing Activities
Deferred offering costs - net	(13,702)	771,954
Repayments of short term business financing - net	(16,107)	(1,061,481)
Warrant Exercises	7,666,503
(Repayments of) loans payable – related parties - net		(48,955)
Issuance of common stock - net		10,198,548
Proceeds from development incentive advances	1,594,557
(Repayments of) proceeds from loans payable - net	(265,504)	4,964,200
Net cash provided by financing activities	8,965,747	14,824,266
Net Increase in Cash and Cash Equivalents and Restricted Cash	3,722,178	1,183,035
Cash and Cash Equivalents and Restricted Cash - beginning of the period	2,176,402	1,106,998
Cash and Cash Equivalents and Restricted Cash - end of the period	5,898,580	2,290,033
Cash and Cash Equivalents	4,798,580	1,190,033
Restricted Cash	1,100,000	1,100,000
Total Cash and Cash Equivalents and Restricted Cash	5,898,580	2,290,033
Supplemental Disclosures of Cash Flow Information
Cash paid for income taxes
Cash paid for interest	5,179,748	1,444,428
Noncash operating activities:
Acquisition of New Operating Lease Right-of-Use Assets	155,045,761
Noncash financing activities:
Conversion of debt to common stock and additional paid-in capital	7,847,630	3,924,468
Common stock issued in exchange for warrants		4,635,245
Accrued deferred offering costs	$ 350,000